The mean estimated OS ± standard error was 86.6 ± 13.4 months in patients with a higher CD8+ TIL density in the initial tumor and 117.6 ± 22.3 months in those with a lower CD8+ TIL density in the initial tumor, showing no significant difference between the two (p = 0. This evidence concerns the gene CD8A and neoplasm.